1. The right to health and medicines: the case of recent multilateral negotiations on public health, innovation and intellectual property;Velasquez;Dev World Bioeth,2014
2. 53. Musungu, S. F. , Oh, C. . The use of flexibilities in TRIPS by developing countries: can they promote access to medicines? 2006. https://apps.who.int/iris/handle/10665/43503 (accessed October 19, 2021).
3. 18. World Health Organization. Pharmaceutical system transparency and accountability assessment tool: good governance for medicines – progressing access in the SDG era. 2018. https://apps.who.int/iris/handle/10665/275370 (accessed December 12, 2021).
4. 9. US Food and Drug Administration. Biological product definitions. n.d. www.fda.gov/files/drugs/published/Biological-Product-Definitions.pdf (accessed February 17, 2022).
5. 54. World Trade Organization. What are intellectual property rights? 2021. www.wto.org/english/tratop_e/trips_e/intel1_e.htm (accessed October 19, 2021).